Bio-Rad Appoints Jon DiVincenzo As President And Chief Operating Officer, Effective September 9, 2024, Replacing Andy Last, Who Is Retiring
Bio-Rad Appoints Jon DiVincenzo As President And Chief Operating Officer, Effective September 9, 2024, Replacing Andy Last, Who Is Retiring
Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo will join the company as President and Chief Operating Officer, effective September 9, 2024, replacing Andy Last, who is retiring.
全球貨幣生命科學研究和臨床診斷產品領軍企業Bio-Rad Laboratories, Inc.（紐交所:BIO）今天宣佈Jon DiVincenzo將於2024年9月9日加入該公司擔任總裁兼首席運營官，接替即將退休的Andy Last。
Mr. DiVincenzo joins Bio-Rad from Labcorp Holdings Inc., a global provider of comprehensive laboratory services, where he held various global operational and commercial leadership roles across the company's several business units. Most recently, he served as Executive Vice President and President, Central Laboratories and International. Prior to LabCorp, Mr. DiVincenzo was President of the Environmental Health Division at PerkinElmer, a global company focused on diagnostics, life science research, food quality, environmental health and industrial testing. He also served as Chief Executive Officer of Enzymatics, a privately held molecular biology reagents company. Prior to that, Mr. DiVincenzo held roles of increasing responsibility in the Biosciences and Lab Water businesses of EMD Millipore, a subsidiary of Merck KGaA. He holds a Bachelor of Science degree in mechanical engineering from Northeastern University.
DiVincenzo先生之前在Labcorp Holdings Inc.工作，Labcorp Holdings Inc.是一家提供全面實驗室服務的全球服務提供商，他曾在該公司的多個業務部門擔任全球運營和商業領導職務。 最近，他擔任執行副總裁兼中央實驗室和國際總裁。在加入LabCorp之前，DiVincenzo先生曾在PerkinElmer擔任環境健康部門總裁，PerkinElmer是一家全球專注於診斷、生命科學研究、食品質量、環境健康和工業測試的公司。他還擔任過Enzymatics的首席執行官，Enzymatics是一傢俬人控股的分子生物學試劑公司。在此之前，DiVincenzo先生在默沙東子公司EMD Millipore的生物科學和實驗室水業務中擔任越來越重要的職務。他擁有美國東北大學機械工程學士學位。
譯文內容由第三人軟體翻譯。